GSDMD Inhibition: A New Target in Atopic Dermatitis?
Atopic dermatitis patients may benefit from novel therapies targeting GSDMD, a protein that appears to suppress keratinocyte differentiation. Inhibiting GSDMD could offer an alternative or adjunct to existing treatments like JAK inhibitors.
Do Condition-Specific Growth Charts Improve Care in Alagille Syndrome?
Growth charts tailored for Alagille Syndrome (ALGS) could refine the assessment of malnutrition in these children, but questions remain about their broad applicability. Clinicians should view these new charts cautiously, considering the limitations of the underlying data and the potential for misinterpretation.
Smoking and Cataracts: A Clearer Vision of Prevention
Smoking-related cataracts contribute significantly to global vision impairment, a burden potentially reduced with aggressive smoking cessation strategies. Primary care physicians are uniquely positioned to communicate the tangible risk of vision loss to motivate patients towards quitting.
SPI1 Mutations Expand the Agammaglobulinemia Genetic Map
A novel de novo SPI1 mutation has been identified in a Chinese patient with agammaglobulinemia, adding another piece to the complex genetic puzzle of this primary immunodeficiency. This finding suggests that SPI1 should be considered in the diagnostic workup of patients with unexplained B-cell deficiency, particularly in cases where other known genetic causes have been excluded.
Lorlatinib and the Enigma of Autoantibody-Negative Diabetes
Patients on lorlatinib may develop diabetes with unusual characteristics, including the absence of typical autoantibodies. This presents a diagnostic challenge, requiring clinicians to consider drug-induced etiologies even when initial immunological markers are negative.
